Quetiapine May Be Better Option Than Lithium for Treatment-Resistant Depression

Watchdoq March 26, 2025
(MedPage Today) -- Quetiapine (Seroquel) was more clinically effective than lithium as a first-line augmentation option in treatment-resistant depression and likely was more cost-effective, a pragmatic multicenter clinical trial suggested.
Over...

Read Full Article